SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001437749-16-036473
Filing Date
2016-08-04
Accepted
2016-08-04 16:30:12
Documents
1
Group Members
CHINA PIONEER PHARMA HOLDINGS LTDPIONEER PHARMA (HONG KONG) CO LTD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A pion20160804_sc13da.htm SC 13D/A 118858
  Complete submission text file 0001437749-16-036473.txt   120451
Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Subject) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-83670 | Film No.: 161807895
SIC: 2834 Pharmaceutical Preparations

Mailing Address 33A CHANDER ROAD SINGAPORE U0 219539
Business Address 33A CHANDER ROAD SINGAPORE U0 219539 65-98116356
Pioneer Pharma (Singapore) Pte. Ltd. (Filed by) CIK: 0001558885 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: SC 13D/A